Barclays initiated coverage of Legence (LGN) with an Equal Weight rating and $34 price target The firm is positive on the company’s data center and life science growth prospects, but says expectations on its future growth are high.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN: